Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?

Mahsoem Ali; Lenka N. C. Boyd; Elisa Giovannetti; Geert Kazemier

doi:10.1200/JCO-24-02080

Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?

Mahsoem Ali
, Lenka N. C. Boyd
, Elisa Giovannetti
, Geert Kazemier^*

^*Corresponding author for this work

Department of Radiology, Amsterdam Umc, Location Vrije Universiteit
Amsterdam UMC
AIRC Start-Up Unit

Research output: Contribution to journal › Comment/Letter to the editor › Academic

15 Downloads (Pure)

Original language	English
Article number	2080
Pages (from-to)	1041-1043
Number of pages	3
Journal	Journal of clinical oncology
Volume	43
Issue number	8
Early online date	2025
DOIs	https://doi.org/10.1200/JCO-24-02080
Publication status	Published - 10 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/JCO-24-02080

Should-total-neoadjuvant-therapy-be-the-first-line-treatment-for-patients-with-locally-advanced-rectal-cancer.pdfFinal published version, 247 KBLicence: Taverne

Cite this

@article{c4b9213709bd42829a9c0d3a3fccf78d,

title = "Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?",

author = "Mahsoem Ali and Boyd, \{Lenka N. C.\} and Elisa Giovannetti and Geert Kazemier",

year = "2025",

month = mar,

day = "10",

doi = "10.1200/JCO-24-02080",

language = "English",

volume = "43",

pages = "1041--1043",

journal = "Journal of clinical oncology",

issn = "0732-183X",